Ashland Completes Expansion of HEC Production in China
Ashland recently completed aln expansion for Natrosol hydroxyethylcellulose (HEC) in Nanjing, China, increasing the company’s manufacturing output at the site by nearly 30 percent.
Key markets for HEC include coatings, personal care, oil and gas, construction, and pharmaceuticals.
“This capacity expansion enables us to support our customers’ growing demand for Natrosol HEC,” said Chris Brown, VP and GM, Ashland Coatings. “Continuing to maximize our current network provides Ashland with a better return on capital versus building a new plant while also strengthening our cost position.”
You May Interested In
Glow70/KLOW80 99% China Peptides Warehouse Direct Delivery Lyophilized Powder in Stock
$1.8E+2/UNIT FOB
2026-09-05
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Ashland Advances $60 Million Strategic Manufacturing Network Optimization
-
Ashland Completes Sale of Its Avoca Business to Mane
-
Klil Expands Its Business: Builds An Advanced And Innovative Coating Plant
-
Ashland Signs Definitive Agreement to Sell Its Avoca Business to Mane
-
Ashland sells nutraceutical business to Turnspire Capital Partners
-
Vietnam Successfully Researched Nano-Heat-Insulating Reflective Coatings
-
Ashland Launches Perfectyl Biofunctional for Clear Skin, Utilizes GABA Amino Acid
-
BASF Expands and Upgrades Coating Defoamer Unit at Turkish Plant
-
Middle East Coatings Show 2024——The Largest Gathering for the Coatings Community in the Mena Region
-
PPG’s new paint for a new start initiative to decorate schools worldwide with colorful makeovers
Recommend Reading
-
![Iran Fully Halts Petrochemical Exports as the Middle East Supply System Faces Restructuring]()
Iran Fully Halts Petrochemical Exports as the Middle East Supply System Faces Restructuring
-
![Novo Nordisk Enters High-Stakes Bidding War with Pfizer for Metsera]()
Novo Nordisk Enters High-Stakes Bidding War with Pfizer for Metsera
-
![AstraZeneca and CSPC Strengthen Biologics Manufacturing Partnership in China]()
AstraZeneca and CSPC Strengthen Biologics Manufacturing Partnership in China
-
![Cipla CEO Calls Tirzepatide a High-Science Product with Strong Market Outlook]()
Cipla CEO Calls Tirzepatide a High-Science Product with Strong Market Outlook
-
![Pfizer Seen Holding Strategic Edge in Bidding Battle for Metsera]()
Pfizer Seen Holding Strategic Edge in Bidding Battle for Metsera
-
![Downstream Rigid Demand Procurement: Cautiously Observing—Polyester Staple Fiber Prices Slightly Weaken]()
Downstream Rigid Demand Procurement: Cautiously Observing—Polyester Staple Fiber Prices Slightly Weaken
-
![Premium Global Chemical Sourcing Requests (16-18Apr, 2026)]()
Premium Global Chemical Sourcing Requests (16-18Apr, 2026)
-
![Business Society’s DOP Market Outlook on August 21, 2026: Clearly Upward Trend]()
Business Society’s DOP Market Outlook on August 21, 2026: Clearly Upward Trend
-
![Business Society’s Market Outlook for China’s Hydrofluoric Acid on August 21, 2026: A Volatile Pattern]()
Business Society’s Market Outlook for China’s Hydrofluoric Acid on August 21, 2026: A Volatile Pattern
-
![Business Society’s Market Outlook for China’s Hydrofluoric Acid on August 20, 2026: A Volatile Pattern]()
Business Society’s Market Outlook for China’s Hydrofluoric Acid on August 20, 2026: A Volatile Pattern
